Cloning Resources
  Recent News |  Tags |  Organ & Tissue Cloning |  Animal Cloning |  Definitions |  Archives |  About |  Newsletter |  Subscribe to CloningResources.com RSS Fee Subscribe

Gene Therapy: Identifying Where Genes Can Successfully Integrate (8/7/2007)

Tags:
gene therapy

Gene therapy -- whereby a retrovirus that integrates into the genome of a treated patient is used to deliver the gene of interest -- has been used to treat some individuals with inherited diseases such as X-linked SCID, a disease that causes widespread immunosuppression and therefore susceptibility to infection.

However, a small number of the treated individuals developed leukemia-like diseases because the retrovirus integrated into the genome at a site(s) that caused the cells to divide uncontrollably.

Analysis of the sites of retroviral integration in individuals treated with gene therapy is therefore of utmost importance to the further development of such gene therapy approaches and three studies that appear in the August issue of the Journal of Clinical Investigation address this issue.

The three studies -- reported by researchers from the National Center for Tumor Diseases, Heidelberg, Germany; University College London, London, United Kingdom; and the San Raffaele Telethon Institute for Gene Therapy, Milan, Italy -- indicate that the retroviruses used to deliver the genes of interest in these studies, gammaretroviruses, integrated near the 5" ends of genes that are active in the treated cell population.

Although the diversity of the detected retroviral integration sites decreased following transplantation into patients because the treated cells differentiated, the sites detected remained at the 5" end of genes active in the cell populations analyzed. Importantly, the retrovirus integration sites observed in cells from successfully treated patients were not significantly different from those observed in cells from patients that went on to develop leukemia-like disease.

As discussed in the accompanying commentary by Frederic Bushman from the University of Pennsylvania, Philadelphia, these studies are critical if researchers are to determine whether the dangers of retroviral gene therapy can be predicted and/or eliminated.

Note: This story has been adapted from a news release issued by Journal of Clinical Investigation

Mortgage - Car Insurance - Cheap Car Insurance - Cheap Flights

Post Comments:

Search

Recent Articles
Embryonic pathway delivers stem cell traits 5/16/2008

New role found for a cardiac progenitor population 5/15/2008

Conference to Highlight Rochester Stem Cell Research 5/14/2008

Development of embryonic stem cells into tissue-specific cells demonstrated 5/13/2008

UCI awarded $27.2 million for new stem cell building 5/11/2008

$43M grant will help fund state-of-the-art stem cell facility at Stanford 5/11/2008

$27M for New Stem Cell Research Facility 5/10/2008

UC Santa Cruz awarded $7.2 million grant for stem cell research center 5/9/2008

Nanosurgery on a Specially Designed Microchip Reveals Anesthetics Interfere with Nerve Regeneration Process 5/8/2008

Test of maturity for stem cells 5/8/2008

Stem researchers demonstrate safety of gene therapy using adult stem cells 5/7/2008

Researchers find novel way to repair airway injuries 5/6/2008

Controlling embryonic fate by association 5/5/2008

Stem cell researchers create heart and blood cells from reprogrammed skin cells 5/4/2008

Georgia Stem Cell Initiative symposium on May 22 5/3/2008

  Archives |  Submit News |  Advertise With Us |  Contact Us |  Links
All contents © 2000 - 2009 Web Doodle, LLC. All rights reserved.
Web Doodle, LLC does not provide medical advice, diagnosis or treatment. Please read our disclaimer